The expression of BMI1/PCGF4 has correlated with disease progression and the prognosis of myelodysplastic syndrome (MDS) [23], the prognoses of acute myeloid leukemia (AML) and chronic myeloid leukemia [24]. This evidence concerns the gene BMI1 and myelodysplastic syndrome.